skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

Since the discovery of the microbiome, biomedical research has been highly focused on understanding how exactly its interactions within the body contribute to health and disease, and drug development companies are very interested in understanding the potential of microbiome modulating therapies.


The topics covered include:

  • Major therapeutic areas of drug development including infectious disease, gastrointestinal disorders, metabolic diseases, dermatological conditions, and early research in cancers and neurological indications
  • The time trend in microbiome drug development
  • The current development landscape, including number of microbiome modulators at each development phase
  • The top companies investing the most in this research area, and microbiome research collaborations